Deaths among heroin users in and out of methadone treatment

Journal of Maintenance in the Addictions

Volumn 1, Issue 4, 2000, Pages 45-61

  Desmond, David P ^a   Maddux, James F ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b University of Texas Health Science Center at San Antonio   (United States)

Author keywords

Methadone maintenance; Mortality; Opioid dependence; Overdose

Indexed keywords

EID: 21744433894     PISSN: 10911332     EISSN: 15407624     Source Type: Journal    
DOI: 10.1300/J126v01n04_05     Document Type: Article

References (51)

1. Baden, M. M., 1970. Methadone related deaths in New York City. International Journal of the Addictions, 5:489–498.
2. Barrett, D. H., Luk, A. J., Parrish, R. G., and Jones, T. S., 1996. An investigation of medical examiner cases in which methadone was detected, Harris County, Texas, 1987–1992. Journal of Forensic Sciences, 41:442–448.
3. Bewley, T. H., Ben-Arie, O., and James, I. P., 1968. Morbidity and mortality from heroin dependence:Survey of heroin addicts known to Home Office. British Medical Journal, 1:725–32.
4. Caplehorn, J. R.M., Dalton, M. S., Haldar, F., Petrenas, A M., and Nisbet Methadone, J. G., 1996. Maintenance and addicts' risk of fatal heroin overdose. Substance Use and Misuse, 31(2):177–196.
5. Caplehorn, J. R.M., and Ross, M. W., 1995. Methadone maintenance and the likelihood of risky needle sharing. International Journal of Addictions, 30:685–698.
6. Chappel, J. N., Mays, V. M., and Senay, E. C., 1973. Death and treatment of drug addiction:A five year study of deaths occurring to members of the Illinois Drug Abuse Program, Vol. 1, 530–537. New York:National Association for the Prevention of Addiction to Narcotics. Proceedings of the 5th National Conference on Methadone Treatment
7. Cherubin, C., McCusker, J., Baden, M., Kavaler, F., and Amsel, Z., 1972. The epidemiology of death in narcotic addicts. American Journal Epidemiology, 96:11–22.
8. Concool, B., Smith, H., and Stimmel, B., 1979. Mortality rates of persons entering metha-done maintenance:A seven year study. American Journal of Drug and Alcohol Abuse, 6:345–353.
9. Cooper, J. R., 1989. Methadone treatment and acquired immunodeficiency syndrome. Journal of the American Medical Association, 262(12):1664–1668.
10. Cottrell, D., Childs-Clarke, A., and Ghodse, A. H., 1985. British opiate addicts:An 11-year follow-up. British Journal of Psychiatry, 146:448–450.
11. Cushman, P., 1977. Ten years of methadone maintenance treatment:Some clinical observations. American Journal of Drug and Alcohol Abuse, 4:543–553.
12. Des Jarlais, D. C., 1984. “Research design, drug use, and deaths:Cross study comparisons”. In The Social and Medical Aspects of Drug Abuse, Edited by:Serban, G., 229–235. Jamaica, NY:Spectrum Publications.
13. Dole, V. P., and Nyswander, M., 1965. A medical treatment for diacetylmorphine (heroin) addiction:A clinical trial with methadone hydrochloride. Journal of the American Medical Association, 193:80–84.
14. Drummer, O. H., Opeskin, K., Syrjanen, M., and Cordner, S. M., 1992. Methadone toxicity causing death in ten subjects starting on a methadone maintenance program. American Journal of Forensic Medicine and Pathology, 13:346–350.
15. Duvall, H. J., Locke, B. Z., and Brill, L., 1963. Follow-up study of narcotic drug addicts five years after hospitalization. Public Health Reports, 78:185–93.
16. Farrell, M., Ward, J., Mattick, R., Hall, W., Stimson, G. V., Des Jarlais, D., Gossop, M., and Strang, J., 1994. Methadone maintenance treatment in opiate dependence:A review. British Medical Journal, 309:997–1001.
17. Fugelstad, A., Rajs, J., Bottiger, M., and De Verdier, M. G., 1995. Mortality among HIV-in-fected intravenous drug addicts in Stockholm in relation to methadone treatment. Addiction, 90:711–716.
18. Gearing, F. R., Deaths before, during, and after methadone maintenance treatment in New York City. Proceedings of the Fourth National Conference on Methadone Treatment. pp.493–494. New York:National Association for Prevention of Addiction to Narcotics.
19. Gearing, F. R., and Schweitzer, M. D., 1974. An epidemiologic evaluation of long-term methadone maintenance treatment for heroin addiction. American Journal of Epidemiology, 100:102–112.
20. Gossop, M., and Grant, M., 1991. A six country survey of the content and structure of heroin treatment programmes using methadone. British Journal of Addiction, 86:1151–1160.
21. Greene, M. H., Luke, J. L., and DuPont, R. L., Opiate overdose deaths in the District of Columbia. Part II-Methadone-related fatalities. Journal of Forensic Sciences, 19575–584.
22. Grönbladh, L., Öhlund, L.S., and Gunne, L. M., Mortality in heroin addiction:Impact of methadone treatment. Acta Psychiatrica Scandinavica, 82223–227.
23. Gunne, L., and Grönbladh, L., The Swedish methadone maintenance program:A controlled study. Drug and Alcohol Dependence, 7249–256.
24. Hser, Y., Anglin, M. D., and Powers, K., A 24-year follow-up of California narcotics addicts. Arch General Psychiatry, 50577–584.
25. James, I. P., Suicide and mortality amongst heroin addicts in Britain. British Journal of Addiction, 62391–398.
26. Joe, G. W., Lehman, W., and Simpson, D. D., Addict death rates during a four-year posttreatment follow-up. American Journal of Public Health, 72703–709.
27. Joe, G. W., and Simpson, D. D., Mortality rates among opioid addicts in a longitudinal study. American Journal of Public Health, 77347
28. Kreek, M. J., Medical safety and side effects of methadone in tolerant individuals. Journal of the American Medical Association, 223665–668.
29. Lowinson, J. H., Marion, I. J., Joseph, H., and Dole, V. P., “Methadone maintenance”. In Substance Abuse:A Comprehensive Textbook, Edited by:Lowinson, J. H., Ruiz, P., Millman, R. B., and Langrod, J. G., 550–561. Baltimore:Williams & Wilkins.
30. Maddux, J. F., and Desmond, D. P., Careers of Opioid Users, New York:Praeger Publishers.
31. Maddux, J. F., and Desmond, D. P., Outcomes of methadone maintenance 1 year after admission. Journal of Drug Issues, 27225–238.
32. Manning, T., Bidanset, J. H., Cohen, S., and Lukash, L., Evaluation of AbuscreenR for methadone. Journal of Forensic Sciences, 21112–120.
33. Marks, J., Deaths from methadone and heroin (letter). Lancet, 343976
34. Mason, P., Mortality among young heroin addicts. Journal of Mount Sinai Hospital, 344–10.
35. Nadler, J., Fumia, F., Cherubin, C., and Gearing, F., Deaths of narcotic addicts in New York City in 1971:Those reported to be using methadone. International Journal of the Addictions, 10135–147.
36. Newcombe, R., Live and let die:Is methadone more likely to kill you than heroin?. Druglink, Jan-Feb.
37. O'Donnell, J. A., Narcotic Addicts in Kentucky, Chevy Chase, MD:U.S. Department of Health, Education, and Welfare.
38. Olsen, G. D., Wilson, J. E., and Robertson, G. E., Respiratory and ventilatory effects of methadone in healthy women. Clinical Pharmacology and Therapeutics, 29373–380.
39. Poser, W., Koc, J., and Ehrenreich, H., Methadone treatment can reduce mortality (letter). British Medical Journal, 310463
40. Sells, S. B., Chatham, L. R., and Retka, R. L., A study of differential death rates and causes of death among 9276 opiate addicts during 1970–1971. Contemporary Drug Problems, 1665–706.
41. Selwyn, P. A., Hartel, D., Wasserman, W., and Drucker, E., 1989. Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. American Journal of Public Health, 79:1358–1362.
42. Senay, E. C., 1994. “Opiods:Methadone maintenance”. In The American Psychiatric Press Textbook of Substance Abuse Treatment, Edited by:Galanter, M., and Kleber, H. D., 209–221. Washington, DC:American Psychiatric Press.
43. Serpelloni, G., Carrieri, M. P., Rezza, G., Morganti, S., Gomma, M., and Binkin, N., Methadone treatment as a determinant of HIV risk reduction among injecting drug users:a nested case-control study. AIDS Care, 6(2)215–220.
44. Substance Abuse and Mental Health Services Administration. 1996. Annual Medical Examiner Data Series I, Number 14-B, DHHS Publication (SMA) 96, Bethesda, MD:SAMHSA.
45. Tu, T., 1951. Statistical studies on the mortality rates and the causes of death among the opium addicts in Formosa. Bulletin on Narcotics, 3:9–112.
46. Vaillant, G. E., 1966. Twelve year followup of New York narcotic addicts, II. The natural history of a chronic disease. New England Journal of Medicine, 275:1282–1288.
47. Verebely, K., Volavka, J., Mule, S., and Resnick, R., 1975. Methadone in man:Pharmacoki-netic and excretion studies in acute and chronic treatment. Clinical Pharmacology and Therapeutics, 18:180–189.
48. Watterson, O., Simpson, D. W., and Sells, S. B., 1975. Death rates and causes of death among opioid addicts in community drug treatment programs, 1970–1973. American Journal of Drug and Alcohol Abuse, 2:99–111.
49. Weber, R., Ledergerber, B., Opravil, M., Siegenthaler, W., and Luthy, R., 1990. Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. British Medical Journal, 301:1362–1365.
50. Wille, R., 1981. Ten-year follow-up of a representative sample of London heroin addicts:Clinic attendance, abstinence and mortality. British Journal of Addiction, 76:259–266.
51. Zimney, E. L., and Luke, J. L., 1981. Narcotic-related deaths in the District of Columbia, 1971–1979. Journal of Forensic Sciences, 26:462–469.